Inferior prognostic outcome in acute promyelocytic leukemia with alterations of FLT3 gene

References

• Lowenberg B, Downing J R, Burnett A. Acute myeloid leukemia. N Engl J Med 1999; 341: 1051–1062
   PubMed Web of Science ®Google Scholar
• Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322–2333
   PubMed Web of Science ®Google Scholar
• Avvisati G, Tallman M S. All-trans retinoic acid in acute promyelocytic leukaemia. Best Pract Res Clin Haematol 2003; 16: 419–432
   PubMed Web of Science ®Google Scholar
• Tallman M S. Curative therapeutic approaches to APL. Ann Hematol 2004; 83(Suppl 1)S81–S82
   PubMedGoogle Scholar
• Birg F, Courcoul M, Rosnet O, Bardin F, Pebusque M J, Marchetto S, et al. Expression of the FMS/KIT-like gene FLT3 in human acute leukemias of the myeloid and lymphoid lineages. Blood 1992; 80: 2584–2593
   PubMed Web of Science ®Google Scholar
• Meierhoff G, Dehmel U, Gruss H J, Rosnet O, Birnbaum D, Quentmeier H, et al. Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines. Leukemia 1995; 9: 1368–1372
   PubMed Web of Science ®Google Scholar
• Stirewalt D L, Radich J P. The role of FLT3 in haematopoietic malignancies. Nat Rev Cancer 2003; 3: 650–665
   PubMed Web of Science ®Google Scholar
• Rosnet O, Mattei M G, Marchetto S, Birnbaum D. Isolation and chromosomal localization of a novel FMS-like tyrosine kinase gene. Genomics 1991; 9: 380–385
   PubMed Web of Science ®Google Scholar
• Gilliland D G, Griffin J D. The roles of FLT3 in hematopoiesis and leukemia. Blood 2002; 100: 1532–1542
   PubMed Web of Science ®Google Scholar
• Kiyoi H, Naoe T, Nakano Y, Yokota S, Minami S, Miyawaki S, et al. Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood 1999; 93: 3074–3080
   PubMed Web of Science ®Google Scholar
• Abu-Duhier F M, Goodeve A C, Wilson G A, Gari M A, Peake I R, Rees D C, et al. FLT3 internal tandem duplication mutations in adult acute myeloid leukaemia define a high-risk group. Br J Haematol 2000; 111: 190–195
   PubMed Web of Science ®Google Scholar
• Schnittger S, Schoch C, Dugas M, Kern W, Staib P, Wuchter C, et al. Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood 2002; 100: 59–66
   PubMed Web of Science ®Google Scholar
• Rombouts W J, Blokland I, Lowenberg B, Ploemacher R E. Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3 gene. Leukemia 2000; 14: 675–683
   PubMed Web of Science ®Google Scholar
• Nakao M, Yokota S, Iwai T, Kaneko H, Horiike S, Kashima K, et al. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia 1996; 10: 1911–1918
   PubMed Web of Science ®Google Scholar
• Thiede C, Steudel C, Mohr B, Schaich M, Schakel U, Platzbecker U, et al. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood 2002; 99: 4326–4335
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Kiyoi H, Nakano Y, Suzuki R, Kodera Y, Miyawaki S, et al. Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies. Blood 2001; 97: 2434–2439
   PubMed Web of Science ®Google Scholar
• Kiyoi H, Naoe T, Yokota S, Nakao M, Minami S, Kuriyama K, et al. Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho). Leukemia 1997; 11: 1447–1452
   PubMed Web of Science ®Google Scholar
• Noguera N I, Breccia M, Divona M, Diverio D, Costa V, De Santis S, et al. Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol. Leukemia 2002; 16: 2185–2189
   PubMed Web of Science ®Google Scholar
• Shih L Y, Kuo M C, Liang D C, Huang C F, Lin T L, Wu J H, et al. Internal tandem duplication and Asp835 mutations of the FMS-like tyrosine kinase 3 (FLT3) gene in acute promyelocytic leukemia. Cancer 2003; 98: 1206–1216
   PubMed Web of Science ®Google Scholar
• Au W Y, Fung A, Chim C S, Lie A K, Liang R, Ma E S, et al. FLT-3 aberrations in acute promyelocytic leukaemia: clinicopathological associations and prognostic impact. Br J Haematol 2004; 125: 463–469
   PubMed Web of Science ®Google Scholar
• Callens C, Chevret S, Cayuela J M, Cassinat B, Raffoux E, de Botton S, et al. Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group. Leukemia 2005; 19: 1153–1160
   PubMed Web of Science ®Google Scholar
• Gale R E, Hills R, Pizzey A R, Kottaridis P D, Swirsky D, Gilkes A F, et al. The relationship between FLT3 mutation status, biological characteristics and response to targeted therapy in acute promyelocytic leukemia. Blood 2005, Aug 16 [Epub ahead of print]
   Web of Science ®Google Scholar
• Kuchenbauer F, Schoch C, Kern W, Hiddemann W, Haferlach T, Schnittger S. Impact of FLT3 mutations and promyelocytic leukaemia-breakpoint on clinical characteristics and prognosis in acute promyelocytic leukaemia. Br J Haematol 2005; 130: 196–202
   PubMed Web of Science ®Google Scholar
• Andersson A, Johansson B, Lassen C, Mitelman F, Billstrom R, Fioretos T. Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients. Eur J Haematol 2004; 72: 307–313
   PubMed Web of Science ®Google Scholar
• Kong S Y, Ki C S, Lee S G, Hong S A, Kim J W, Kim S H, et al. Analysis of FLT3-activaing mutations in 77 patients with acute myelogenous leukemia: Association with WHO classification [abstract]. Korean J Hematol 2003; 38: 44
   Google Scholar